FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 60 filers reported holding FATE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $39,782 | -99.5% | 10,637 | -97.2% | 0.00% | -100.0% |
Q3 2022 | $8,442,000 | -9.6% | 376,683 | -0.1% | 0.01% | 0.0% |
Q2 2022 | $9,341,000 | -32.7% | 376,949 | +5.2% | 0.01% | -25.0% |
Q1 2022 | $13,887,000 | -32.5% | 358,192 | +1.7% | 0.01% | -25.0% |
Q4 2021 | $20,560,000 | -9.3% | 352,336 | -8.5% | 0.02% | -20.0% |
Q3 2021 | $22,676,000 | +0.4% | 385,187 | +48.0% | 0.02% | 0.0% |
Q2 2021 | $22,583,000 | +386.4% | 260,293 | +359.2% | 0.02% | +400.0% |
Q1 2021 | $4,643,000 | -16.3% | 56,683 | -7.1% | 0.00% | -33.3% |
Q4 2020 | $5,547,000 | +127.5% | 61,000 | 0.0% | 0.01% | +100.0% |
Q3 2020 | $2,438,000 | +92.1% | 61,000 | +64.9% | 0.00% | +50.0% |
Q2 2020 | $1,269,000 | +54.4% | 37,000 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $822,000 | -53.3% | 37,000 | -58.9% | 0.00% | -50.0% |
Q4 2019 | $1,761,000 | +5.6% | 90,000 | -16.2% | 0.00% | 0.0% |
Q3 2019 | $1,668,000 | -14.4% | 107,400 | +11.9% | 0.00% | 0.0% |
Q2 2019 | $1,949,000 | +84.9% | 96,000 | +60.0% | 0.00% | +100.0% |
Q1 2019 | $1,054,000 | +36.9% | 60,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $770,000 | -60.6% | 60,000 | -50.0% | 0.00% | -50.0% |
Q3 2018 | $1,955,000 | +1050.0% | 120,000 | +700.0% | 0.00% | – |
Q2 2018 | $170,000 | -88.6% | 15,000 | -90.2% | 0.00% | -100.0% |
Q1 2018 | $1,496,000 | +41.3% | 153,250 | -11.5% | 0.00% | +100.0% |
Q4 2017 | $1,059,000 | +100.9% | 173,250 | +30.3% | 0.00% | 0.0% |
Q3 2017 | $527,000 | +227.3% | 133,000 | +167.6% | 0.00% | – |
Q2 2017 | $161,000 | -48.4% | 49,700 | -27.6% | 0.00% | – |
Q1 2017 | $312,000 | – | 68,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |